Preprint · CC-BY
via OpenAlex
Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: A pooled analysis of four prospective studies
Pierre‐Antoine Dugué, Clara Bodelón, Felicia Fei‐Lei Chung, Hannah R Brewer, Srikant Ambatipudi, Joshua Neil Sampson, Cyrille Cuenin, Véronique Chajès, Isabelle Romieu, Giovanni Fiorito, Carlotta Sacerdote, Vittorio Krogh, Salvatore Panico, Rosario Tumino, Paolo Vineis
Research Square · 2022 · ▲ 2 citations
Abstract
Abstract Background: DNA methylation in blood may reflect adverse exposures accumulated over the lifetime and could therefore provide potential improvements in the prediction of cancer risk. A substantial body of research has shown associations between epigenetic aging and risk of disease, including cancer. Here we aimed to study epigenetic measures of aging and lifestyle-related factors in association with risk of breast cancer.Methods: Using data from four prospective case-control studies nested in three cohorts of European ancestry participants, including a total of 1,655 breast cancer cases, we calculated three methylation-based measures of lifestyle factors (body mass index, tobacco smoking, and alcohol consumption), and seven measures of epigenetic aging (Horvath-based, Hannum-based, PhenoAge and GrimAge). All measures were regression-adjusted for their respective risk factors and expressed per standard deviation. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using conditional or unconditional logistic regression, and pooled using fixed-effects meta-analysis. Subgroup analyses were conducted by age at blood draw, time from blood sample to diagnosis, estrogen receptor-positivity status, and tumour stage.Results: None of the measures of epigenetic aging were associated with risk of breast cancer in the pooled analysis: Horvath ‘age acceleration’ (AA): OR =1.02, 95%CI: 0.95-1.10; AA-Hannum: OR=1.03, 95%CI :0.95-1.12; PhenoAge: OR=1.01, 95%CI: 0.94-1.09 and GrimAge: OR=1.03, 95%CI: 0.94-1.12, in models adjusting for white blood cell proportions, body mass index, smoking and alcohol consumption. The BMI-adjusted predictor of BMI was associated with breast cancer risk, OR per SD=1.09, 95%CI: 1.01-1.17. Results for the alcohol and smoking methylation-based predictors were consistent with a null association. Risk did not appear to substantially vary by age at blood draw, time to diagnosis or tumour characteristics.Conclusion: We found no evidence that methylation-based measures of aging, smoking or alcohol consumption were associated with risk of breast cancer. A methylation-based marker of BMI was associated with risk and may provide insights into the underlying associations between BMI and breast cancer.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.21203/rs.3.rs-1651806/v1
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Dugué, P., Bodelón, C., Chung, F.F., Brewer, H.R., Ambatipudi, S., Sampson, J.N., Cuenin, C., Chajès, V., Romieu, I., Fiorito, G., Sacerdote, C., Krogh, V., Panico, S., Tumino, R., Vineis, P., Polidoro, S., Baglietto, L., English, D.R., Severi, G., & Giles, G.G. (2022). Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: A pooled analysis of four prospective studies. <em>Research Square</em>. https://doi.org/10.21203/rs.3.rs-1651806/v1
Vancouver
Dugué P, Bodelón C, Chung FF, Brewer HR, Ambatipudi S, Sampson JN, et al. Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: A pooled analysis of four prospective studies. Research Square. 2022. doi:10.21203/rs.3.rs-1651806/v1.
BibTeX
@unpublished{pierreantoine2022Methyl,
title = {Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: A pooled analysis of four prospective studies},
author = {Pierre‐Antoine Dugué and Clara Bodelón and Felicia Fei‐Lei Chung and Hannah R Brewer and Srikant Ambatipudi and Joshua Neil Sampson and Cyrille Cuenin and Véronique Chajès and Isabelle Romieu and Giovanni Fiorito and Carlotta Sacerdote and Vittorio Krogh and Salvatore Panico and Rosario Tumino and Paolo Vineis and Silvia Polidoro and Laura Baglietto and Dallas R. English and Gianluca Severi and Graham G. Giles and Roger Laughlin Milne and Zdenko Herceg and Montserrat García‐Closas and James M. Flanagan and Melissa C. Southey},
journal = {Research Square},
year = {2022},
doi = {10.21203/rs.3.rs-1651806/v1},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Breast Cancer Research 2022
Open access · CC-BY
Methylation-based markers of aging and lifestyle-related factors and risk of breast cancer: a pooled analysis of four prospective studies
Scientific Reports 2019
Open access · CC-BY
DNA methylation-based biological age, genome-wide average DNA methylation, and conventional breast cancer risk factors
International Journal of Cancer 2017
Open access · OA
DNA methylation‐based biological aging and cancer risk and survival: Pooled analysis of seven prospective studies
The Journals of Gerontology Series A 2019
Preprint · OA
A Systematic Review and Meta-analysis of Environmental, Lifestyle, and Health Factors Associated With DNA Methylation Age
Current Alzheimer Research 2021
Preprint · OA
Accelerated Epigenetic Aging in Peripheral Blood does not Predict Dementia Risk
bioRxiv (Cold Spring Harbor Laboratory) 2022
Preprint · CC-BY